ProMIS Neurosciences Doses First Patients in Phase 1b PRECISE-AD Trial of PMN310 for Alzheimer’s Disease
Rapid Enrollment and Dosing of First Patients Encouraging and Underscores Unmet Need for Better Treatment Options for Alzheimer’s Disease Six-month Interim Results Expected in 1H 2026 with Topline ...
‘Duck Dynasty’ star has surgery after ‘horror show’ injury from fall
Phil’s issues have been well-documented of late, with news that he will not be appearing on the upcoming reboot as he battles ...